Implementation of solutions to reduce opioid-induced oversedation and respiratory depression

被引:16
|
作者
Meisenberg, Barry [1 ,2 ]
Ness, John [3 ]
Rao, Sumati [3 ]
Rhule, Jane [2 ]
Ley, Cathaleen [4 ]
机构
[1] Anne Arundel Med Ctr, Ctr Hlth Care Improvement, Annapolis, MD 21401 USA
[2] Anne Arundel Med Ctr, Res Inst, Outcomes Dept, Annapolis, MD 21401 USA
[3] Anne Arundel Med Ctr, Dept Pharm, Annapolis, MD USA
[4] Anne Arundel Med Ctr, Dept Nursing Qual & Res, Annapolis, MD USA
关键词
analgesics; opioid; narcosis; narcotics; patient safety; PAIN MANAGEMENT; SEDATION ASSESSMENT; ADVERSE-EVENTS; PATIENT SAFETY; CARE-UNIT; HYDROMORPHONE; ANESTHESIA;
D O I
10.2146/ajhp160208
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. The implementation of interventions to mitigate the causes of opioid-induced oversedation and respiratory depression (OSRD) is reported. Summary. A single-site retrospective review of eligible rescue naloxone cases was conducted to identify the causes of opioid-induced OSRD in a hospital as well as to identify risk factors. A survey was used to assess potential opioid knowledge deficits among hospitalist prescribers. Based on the findings of the case reviews and results of the opioid knowledge assessments, a series of interventions to address noted deficiencies was implemented over the ensuing months, including enhanced monitoring for sedation, improved clinical decision support in the electronic medical record (EMR), and various adjustments to dosing for high-risk patients. The primary endpoint of our analysis was naloxone use for documented cases of opioid-induced OSRD to determine the effectiveness of the interventions. A mean of 16 OSRD events occurred per quarter before intervention implementation. An average of five risk factors (range, two to six) was found among OSRD cases, most commonly age of >60, obesity, and comorbidities of the kidneys and lungs. Deficiencies of clinical care were found in four inter-related domains: knowledge deficits, inadequate monitoring, failure to leverage the EMR, and cultural issues regarding pain assessments and sedation management. Conclusion. Implementation of solution bundles that utilized an EMR to create meaningful clinical decision support and cultural changes related to pain goals and communication about sedation level at an acute care hospital resulted in a fivefold reduction in OSRD events that has been sustained for two years.
引用
收藏
页码:162 / 169
页数:8
相关论文
共 50 条
  • [41] The pontine respiratory group is involved in opioid-induced respiratory depression in adult rabbits
    Miller, Justin
    Zuperku, Edward
    Stuth, Eckehard
    Hopp, Francis
    Stucke, Astrid
    FASEB JOURNAL, 2014, 28 (01):
  • [42] Incidence of Respiratory Depression and Derivation of a Novel Opioid-Induced Respiratory Depression Risk Prediction Tool
    Dempsey, Susan
    PAIN MANAGEMENT NURSING, 2021, 22 (02) : 238 - 238
  • [43] Predicting opioid-induced oversedation in hospitalised patients: a multicentre observational study
    Garrett, John
    Vanston, Anneliese
    Ogola, Gerald
    da Graca, Briget
    Cassity, Cindy
    Kouznetsova, Maria A.
    Hall, Lauren R.
    Qiu, Taoran
    BMJ OPEN, 2021, 11 (11):
  • [44] Targeting a Non-Opioid Signaling Pathway to Reverse Opioid-Induced Respiratory Depression
    Chang, Andy
    Scharr, Alexandra
    Garcia, Ethan
    Lin, Terra
    Arizabal, Deomar
    DRUG AND ALCOHOL DEPENDENCE, 2024, 260
  • [45] Editorial: Opioid-induced respiratory depression: neural circuits and cellular pathways
    Stucke, Astrid G.
    Levitt, Erica S.
    Montandon, Gaspard
    FRONTIERS IN PHYSIOLOGY, 2023, 14
  • [46] A pharmacological assessment of opioid-induced respiratory depression and potential antagonisn by naltrexone
    Iacono, Giuseppina
    Bell, Rosonald
    Norton, Kevin
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2013, 68 (01) : E43 - E43
  • [47] Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics
    S Sadhasivam
    V Chidambaran
    X Zhang
    J Meller
    H Esslinger
    K Zhang
    L J Martin
    J McAuliffe
    The Pharmacogenomics Journal, 2015, 15 : 119 - 126
  • [48] Opioid-induced respiratory depression is associated with increased tidal volume variability
    Bouillon, T
    Bruhn, J
    Roepcke, H
    Hoeft, A
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2003, 20 (02) : 127 - 133
  • [49] Intranasal Leptin Prevents Opioid-Induced Respiratory Depression in Obese, Opioid Tolerant Mice
    Singer, Michele
    Freire, Carla
    Kim, Lenise
    Pho, Huy
    PHYSIOLOGY, 2023, 38
  • [50] Opioid-Induced Respiratory Depression: Is Hydromorphone Safer Than Morphine? Response
    Khanna, Ashish K.
    Urman, Richard D.
    Overdyk, Frank J.
    ANESTHESIA AND ANALGESIA, 2021, 132 (04): : E61 - E61